Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2021 16:05 ET | Source: Terns Pharmaceuticals, Inc.

Terns Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

-Terns ended 4Q 2020 with $75 million in cash and cash equivalents and completed an upsized initial public offering in February 2021, raising approximately $147 million in gross proceeds to support...
March 22, 2021 07:35 ET | Source: Terns Pharmaceuticals, Inc.

Terns Announces Initiation of Dosing in Phase 1 Clinical Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment of NASH

-TERN-501 is designed to have high metabolic stability, enhanced liver distribution and high selectivity for THR-β- -Top-line data expected in the second half of 2021- FOSTER CITY, Calif., March ...
March 08, 2021 07:00 ET | Source: Terns Pharmaceuticals, Inc.

Terns to Present on VAP-1 and FXR at NASH-TAG Conference 2021

FOSTER CITY, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
February 23, 2021 16:35 ET | Source: Terns Pharmaceuticals, Inc.

Terns to Present at the Cowen 41st Annual Health Care Conference

FOSTER CITY, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
February 10, 2021 07:05 ET | Source: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

FOSTER CITY, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
February 04, 2021 18:54 ET | Source: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

FOSTER CITY, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...